Pathology-Anatomic and Clinical·Evanston, IL

University of Chicago (Endeavor Health – NorthShore Hospitals)

Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
229–267
p10 – p90
Sample N
596
applicants this cycle
This cycle
no tracked aways yet
Match rate
0.7%
4 of 56 applicants
01Cohort funnelthis cycle
N = 596
Applied
596
100.0%
Invited
56
9.4%
Class size
4
0.7%
J-1 visaH-1B visaF-1 visaCategorical
Your fitUniversity of Chicago (Endeavor Health – NorthShore Hospitals) Program

Create a free profile to see your personalized fit

Get started
Contact
AP
Program Director
Ajit Paintal, MD
Email director
KS
Program Coordinator
Kate Seyfarth, BA
Email coordinator
Training sites4 hospitals · Chicago
  • 1
    Evanston Hospital-Northshore University Health System
    Evanston, IL
    Primary
  • 2
    University of Chicago Medical Center
    Chicago, IL
    Sponsor
  • 3
    Ann & Robert H Lurie Children's Hospital of Chicago
    Chicago, IL
    Participant
  • 4
    Office of the Medical Examiner of Cook County
    Chicago, IL
    Participant
Score rangesinvited cohort
USMLE Step 2 CK229267
180205230255280

Level 2 CE data not available

Interview rates
US MD
35%
US DO
24%
US IMG
3%
Non-US IMG
3%
Applicant origin
In-state
55%
Out-of-state
9%
Interview prepPathology-Anatomic and Clinical
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Save this program

Add University of Chicago (Endeavor Health – NorthShore Hospitals) to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Pathology-Anatomic and Clinical.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.